Press release
Competitive Analysis: Leading Companies and New Entrants in the Scleritis Market
Scleritis Market
Projected Growth and Market Size of the Scleritis Market
The scleritis market is anticipated to reach a value of $5.95 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This positive trajectory is fueled by several factors, such as a robust pipeline of biologic drugs targeting ocular inflammation, widespread adoption of teleophthalmology platforms, and the development of more precise anti-inflammatory treatments. Additionally, advancements in imaging technologies and increased awareness programs concerning rare eye diseases are contributing to market expansion. Key trends expected to influence the market include the rise of biologic therapies for ocular inflammation, augmented use of corticosteroids and immunosuppressants, broader use of combination therapy strategies, early detection via advanced diagnostics, and innovation in novel anti-inflammatory ophthalmic drugs.
Download a free report of the scleritis market report:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Driving Innovation in the Scleritis Market
The scleritis market features numerous prominent players including Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche Ltd, Bayer AG, Novartis AG, Teva Pharmaceuticals USA Inc, Baxter International Inc, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc, Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd, Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, and Zydus Pharmaceuticals Inc.
In a notable strategic move, Regeneron Pharmaceuticals Inc., a biotechnology firm based in the US, acquired Oxular Limited in January 2025 for an undisclosed sum. This acquisition equips Regeneron with advanced ocular gene therapy delivery systems, accelerating its readiness for clinical application. Oxular Limited, headquartered in the UK, specializes in developing innovative drug and device treatments for eye disorders like scleritis, enhancing Regeneron's capabilities in precision therapeutics and eye care innovation.
View the full scleritis market report:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Shaping the Future of the Scleritis Market
Significant players in the scleritis space are focusing on creating innovative products such as eye drops designed to treat inflammation effectively while providing patients with non-invasive therapeutic options. Eye drops, which are liquid formulations applied directly to the eyes, help manage conditions involving irritation, dryness, inflammation, or infections. For instance, in May 2023, India-based pharmaceutical company Entod Pharmaceuticals introduced CYCLOTEARS eye drops both domestically and globally. This new treatment employs proprietary SEDDS technology to improve drug delivery and potency, representing a breakthrough in managing inflammatory eye diseases including dry eye disease (DED), ocular myositis, and scleritis. This advancement highlights the evolving landscape of ocular inflammation treatment.
Key Market Segments and Their Role in Scleritis Market Expansion
The scleritis market is systematically categorized into several segments:
1) By Type:
- Anterior Scleritis
- Posterior Scleritis
- Other Types
2) By Treatment Method:
- Medication
- Surgery
- Other Treatment
3) By Distribution Channel:
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
4) By End-User:
- Hospitals
- Specialty Clinics
- Home Healthcare
- Other End-Users
Further breakdowns include:
- Anterior Scleritis divided into Non-Necrotizing and Necrotizing types
- Posterior Scleritis subdivided into Diffuse, Nodular, and Scleritis with Choroidal Involvement
- Other Types encompassing Chronic Scleritis, Recurrent Scleritis, and Infectious Scleritis
This detailed segmentation allows for targeted analysis of product development, treatment preferences, and distribution strategies that collectively drive the scleritis market forward.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Analysis: Leading Companies and New Entrants in the Scleritis Market here
News-ID: 4486658 • Views: …
More Releases from The Business Research Company
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Su …
Understanding the Outlook for the Superficial Punctate Keratitis Treatment Market
The market for superficial punctate keratitis treatment is set to experience significant expansion in the coming years. Forecasts indicate it will reach a value of $7.15 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This positive trajectory is fueled by various factors including the increased use of digital ophthalmology technologies, greater demand for precise…
Key Factors and Emerging Trends Shaping the Surgical Site Infection Control Mark …
The surgical site infection control market is gaining steady traction as healthcare systems worldwide place increasing emphasis on patient safety and infection prevention. With ongoing advancements in technology and growing regulatory support, the sector is set to expand significantly over the coming years. Let's explore the market size projections, key players, emerging trends, and detailed segment analysis shaping this vital healthcare domain.
Projected Market Size and Growth Dynamics of the Surgical…
Leading Companies Solidify Their Presence in the Stroke Risk Calculator App Mark …
The stroke risk calculator app industry is on the verge of significant expansion, driven by technological advancements and a growing emphasis on preventive healthcare. As digital tools become more integrated into clinical workflows, these apps are set to play a crucial role in stroke risk assessment and management over the coming years. Below, we explore the market size projections, key players, trends, and segmentation defining this evolving landscape.
Projected Surge in…
Emerging Growth Patterns Driving Rapid Expansion in the Strabismus and Amblyopia …
The field of digital therapeutics for strabismus and amblyopia is gaining significant attention as technology advances and healthcare needs evolve. This market is set to expand rapidly, driven by innovative treatments and increasing awareness of these visual disorders. Let's explore the current landscape, key players, emerging trends, and important market segments shaping this promising sector.
Projected Market Size and Growth of the Strabismus and Amblyopia Digital Therapeutics Market
The strabismus…
More Releases for Scleritis
Global Scleritis Market Expected to Achieve 8.7% CAGR by 2029: Growth Forecast I …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Scleritis Market Size By 2025?
The overall valuation of the scleritis market has seen robust expansion lately, projected to climb from its 2024 standing of $3.6 billion to reach $3.93 billion by 2025, reflecting a 9.0% compound annual growth rate during this interval. This…
Scleritis Market: Biologic Advances and Early Diagnosis Drive Growth to 2034
Subheadline:
Growing autoimmune disease awareness, biologic drug adoption, and precision ophthalmology tools are driving steady growth in the global scleritis treatment market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72281
Introduction
The Scleritis Market is witnessing gradual but significant growth as advances in biologic drugs, early autoimmune diagnostics, and ocular immunology research reshape disease management strategies.
Valued at USD 270 million in 2024, the market is projected to reach USD 490 million by…
Scleritis Market to Reach USD 2.2 Billion by 2034
Scleritis is a serious inflammatory disease of the sclera, the white outer coating of the eye. It is often associated with systemic autoimmune conditions such as rheumatoid arthritis, granulomatosis with polyangiitis, lupus, and inflammatory bowel disease. Symptoms include severe ocular pain, redness, and potential vision loss if untreated.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72281
Unlike episcleritis, scleritis is more severe and frequently requires systemic immunosuppressive therapy or biologics.…
Strong Growth Ahead: Scleritis Market Size To Grow At Arecord 8.9% Cagr By 2029
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Scleritis Market Size Expected to Be by 2034?
The market for scleritis has seen significant growth in the past few years. The market, which was worth $3.60 billion in 2024, is expected to reach a value of $3.94 billion in 2025, growing at a compound annual growth rate…
Scleritis Market Set to Reach $5.54 Billion by 2029 with 8.9% Yearly Growth
How Are the key drivers contributing to the expansion of the scleritis market?
The increasing prevalence of autoimmune diseases is expected to drive the growth of the scleritis market. Autoimmune diseases are conditions where the body's immune system mistakenly attacks healthy cells and tissues, thinking they are foreign invaders. The rise in autoimmune diseases is linked to genetic predispositions, environmental factors, lifestyle changes, and increased awareness, leading to better diagnosis. Autoimmune…
Scleritis Market Business Opportunities And Regional Outlook 2022-28
According to Precision Business Insights (PBI), latest report, the scleritis market is expected to have a CAGR of 5.8% during the forecast period 2022 to 2028. The primary drivers of the expansion of the global scleritis market include the increasing prevalence of scleritis, the growing geriatric population, developing healthcare infrastructure in economic countries, and technological advancements in treatment and diagnosis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/scleritis-market/ …
